Type 2 diabetes mellitus is a global epidemic accelerating especially in developing world, with increased prevalence in younger age groups. In the UK, it is increasingly diagnosed in children. In the USA, 1 in 3 adults have prediabetes out of which 80% isn’t aware of this condition [1]. Prediabetes is also linked to a higher mortality rate in elderly. Therefore, there is a strong need for universal screening interventions, which would allow preventative measures introduced early enough to stop this debilitating disease. Identification of pre-diabetic patients and increasing their awareness could prevent them from developing diabetes or at least prolong the time prior to need for medical intervention, reducing the cost spent on medical treatment. Moreover, hospitalisation and mortality rates related to viral diseases inclusive of Covid-19 could be greatly reduced by improvement of current health policies for diabetes and prediabetic conditions. In this manuscript, existing universal and targeted interventions that are used to deal with diabetes in the United Kingdom are discussed. The aim of this work is to assess current screening policies in the UK, critically evaluating their strength and limitations to conclude which type of screening interventions used globally might be of interest for implementation in the UK and other countries.